Each center will get $ 90 million to
endow cancer studies in perpetuity or until cancer is no longer a problem.
Not exact matches
Other UT Southwestern researchers involved in the
study were Dr. Ramzi Abdulrahman, Associate Professor of Radiation Oncology; Dr. Arthur Sagalowsky, Professor of Urology and Surgery, co-leader of the Kidney
Cancer Program, who holds The Dr. Paul Peters Chair in Urology in Memory of Rumsey and Louis Strickland; Dr. Ivan Pedrosa, Associate Professor of Radiology and the Advanced Imaging Research Center, co-leader of the Kidney
Cancer Program, who holds the Jack Reynolds, M.D., Chair in Radiology; Dr. Hak Choy, Chair and Professor of Radiation Oncology who holds The Nancy B. & Jake L. Hamon Distinguished Chair in Therapeutic Oncology Research; and Dr. James Brugarolas, Associate Professor of Internal Medicine and Developmental Biology, leader of the Kidney
Cancer Program, and Virginia Murchison Linthicum
Endowed Scholar; and other researchers including Stephen Chun, Dr. Nathan Cannon, and Dr. Nathan Kim.
Gerard A. Silvestri, M.D., M.S., a lung
cancer pulmonologist at the MUSC Hollings Cancer Center who holds the George C. and Margaret M. Hillenbrand Endowed Chair in thoracic oncology, led the
cancer pulmonologist at the MUSC Hollings
Cancer Center who holds the George C. and Margaret M. Hillenbrand Endowed Chair in thoracic oncology, led the
Cancer Center who holds the George C. and Margaret M. Hillenbrand
Endowed Chair in thoracic oncology, led the
study.
«We are at a point in our research where we have validated the efficacy of this combination treatment approach in preclinical animal models, and we now need to define its safety through toxicology and pharmacology
studies,» says Fisher, Thelma Newmeyer Corman
Endowed Chair in
Cancer Research and co-leader of the
Cancer Molecular Genetics research program at VCU Massey, chairman of VCU School of Medicine's Department of Human and Molecular Genetics and director of the VCU Institute of Molecular Medicine.
«By using an animal model to expand tumor cells recently removed from patients, we hoped to re-create more closely what actually happens in patients with pancreatic
cancer rather than by using existing artificial cell lines,» said Wei Zhang, Ph.D., an
endowed Hanes and Willis Family Professor in
cancer at Wake Forest School of Medicine, a part of Wake Forest Baptist, and principal investigator of the
study.